However, despite showing greater expression, serum levels of S100A9 were not a sufficient prognostic measure of glioblastoma at higher transcript levels, while only S100A8 maintained a significant correlation as a marker (Arora et al., 2019). Here, S100A8 is linked to glioblastoma.